Unknown

Dataset Information

0

Localized neuropathic pain: an expert consensus on local treatments.


ABSTRACT: Pain localization is one of the hallmarks for the choice of first-line treatment in neuropathic pain. This literature review has been conducted to provide an overview of the current knowledge regarding the etiology and pathophysiology of localized neuropathic pain (LNP), its assessment and the existing topical pharmacological treatments.Literature review was performed using Medline from 2010 to December 2016, and all studies involving LNP and treatments were examined. A multidisciplinary expert panel of five pain specialists in this article reports a consensus on topical approaches that may be recommended to alleviate LNP and on their advantages in clinical practice.Successive international recommendations have included topical 5% lidocaine and 8% capsaicin for LNP treatment. The expert panel considers that these compounds can be a first-line treatment for LNP, especially in elderly patients and patients with comorbidities and polypharmacy. Regulatory LNP indications should cover the whole range of LNP and not be restricted to specific etiologies or sites. Precautions for the use of plasters must be followed cautiously.Although there is a real need for more randomized controlled trials for both drugs, publications clearly demonstrate excellent risk/benefit ratios, safety, tolerance and continued efficacy throughout long-term treatment. A major advantage of both plasters is that they have proven efficacy and may reduce the risk of adverse events such as cognitive impairment, confusion, somnolence, dizziness and constipation that are often associated with systemic neuropathic pain treatment and reduce the quality of life. Topical modalities also may be used in combination with other drugs and analgesics with limited drug-drug interactions.

SUBMITTER: Pickering G 

PROVIDER: S-EPMC5604568 | BioStudies | 2017-01-01T00:00:00Z

SECONDARY ACCESSION(S): NCT02763592

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC5069616 | BioStudies
2019-01-01 | S-EPMC6503502 | BioStudies
2012-01-01 | S-EPMC3273402 | BioStudies
2020-01-01 | S-EPMC7467465 | BioStudies
2014-01-01 | S-EPMC4232045 | BioStudies
1000-01-01 | S-EPMC4282389 | BioStudies
2020-01-01 | S-EPMC7318692 | BioStudies
2020-01-01 | S-EPMC7765202 | BioStudies
2011-01-01 | S-EPMC3292968 | BioStudies
1000-01-01 | S-EPMC6250696 | BioStudies